ATLANTA, Jan. 12 /PRNewswire-FirstCall/ -- NDCHealth Corporation , a leading provider of healthcare technology and information solutions, today announced the launch of Biotechnology and Injectable Drug Advisor (BIDA), a unique and innovative tool enabling pharmaceutical and biopharmaceutical manufacturers to track actual market utilization of non- retail injectable drugs, the fastest growing segment within the pharmaceutical and biopharmaceutical industries.
The industry’s standard method for tracking sales and marketing performance does not capture sales of many injectable and infused medications. With millions of people already benefiting from medicines developed through biotechnology, and more than 300 biotechnology medicines currently in development, BIDA addresses manufacturers’ emerging need to effectively track specialized and injectable drugs dispensed within the physician office, hospital and institution environment.
Powered by NDCHealth’s Intelligent Health Repository (IHR), the company’s proprietary longitudinal, multi-channel healthcare claims database, BIDA utilizes medical and prescription claims activity to measure the sale and utilization of drugs in physician offices, clinics, specialty pharmacies and hospitals by prescriber, payer, and geography. For drugs with multiple indications, the BIDA solution tracks injectable drug sales by diagnoses, a key factor for aligning budgeting, segmentation and targeting, profiling and promotional messaging with pharmaceutical sales and marketing strategies.
NDCHealth’s Intelligent Health Repository longitudinal healthcare claims database meets all applicable information protection requirements set forth by HIPAA.
BIDA provides manufacturers the information needed to optimize resource allocation and sales forecasting. The data reveals market opportunities and diagnosing trends that enable rapid adjustment of resources and focus based on physician treatment patterns.
“BIDA is yet another example of our ability to leverage data gathered from our NDCHealth Intelligent Network to deliver to the pharmaceutical industry much needed next generation solutions offering multiple healthcare channel views,” said Walter Hoff, chairman and CEO, NDCHealth. “Through our unique role at the center of healthcare, NDCHealth continues to offer our customers unique and powerful insights into the marketplace, as well as tools to enable them to respond quickly and effectively.”
About NDCHealth Corporation
NDCHealth is uniquely positioned in healthcare as the leader in point-of- service systems, electronic connectivity and information solutions to pharmacies, hospitals and health facilities, pharmaceutical manufacturers, physicians and payers. For more information, please visit the company’s website at http://www.ndchealth.com/ .
NDCHealth and NDCHealth Intelligent Network are trademarks of NDCHealth Corporation. All other company and product names mentioned may be trademarks of the company.
NDCHealth Corporation
CONTACT: Robin Wrinn of NDCHealth Corporation, +1-404-728-2214, orrobin.wrinn@ndchealth.com
Web site: http://www.ndchealth.com/